NASDAQ:CUE
Cue Biopharma, Inc.
- Stock
Last Close
1.74
17/05 20:00
Market Cap
119.13M
Beta: 2.00
Volume Today
116.01K
Avg: 186.50K
PE Ratio
−2.14
PFCF: −2.73
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.03 - | 0.05 91.73% | 0.03 34.38% | 0.18 465.31% | 0.01 92.39% | 0.09 554.08% | ||||
cash conversion cycle | -259.01 - | |||||||||
cash per share | 0.31 - | 0.73 132.00% | 3.08 324.57% | 1.95 36.78% | 2.70 38.39% | 2.96 9.76% | 2.06 30.45% | 2.14 4.01% | 1.06 50.45% | |
company equity multiplier | 1.05 - | 1.07 1.76% | 1.09 1.31% | 1.34 22.87% | 1.31 1.76% | 1.26 3.85% | 1.27 0.96% | 1.39 9.13% | 1.66 19.38% | |
days of inventory outstanding | ||||||||||
days of payables outstanding | 371.90 - | |||||||||
days of sales outstanding | 79.68 - | 164.02 105.85% | 76.77 53.20% | 16.78 78.14% | 112.89 572.70% | |||||
dividend yield | ||||||||||
ebit per revenue | -33.87 - | -10.63 68.60% | -14.28 34.30% | -2.93 79.51% | -42.74 1,361.01% | -9.47 77.84% | ||||
ebt per ebit | 1 - | 1.00 0.00% | 1.00 0.00% | 0.99 1.40% | 0.99 0.09% | 0.99 0.29% | 1.00 0.93% | 1.00 0.30% | 0.98 2.03% | |
effective tax rate | -0.02 - | -0.01 47.49% | -0.00 59.25% | -0.01 145.02% | 0.00 135.68% | |||||
enterprise value multiple | -124.02 - | -30.19 75.66% | -7.85 74.01% | -1.95 75.20% | -8.47 335.21% | -6.62 21.84% | -6.85 3.51% | -1.37 80.08% | -1.79 31.22% | |
fixed asset turnover | 0.41 - | 0.48 17.18% | 0.36 26.22% | 1.25 252.91% | 0.12 90.72% | 0.77 562.87% | ||||
free cash flow per share | -0.12 - | -0.31 168.85% | -0.65 106.60% | -1.40 116.30% | -1.40 0.32% | -1.15 17.57% | -1.27 10.16% | -1.18 7.33% | -0.87 25.83% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 0.37 62.59% | ||||
interest coverage | -74.56 - | -41.76 43.99% | ||||||||
inventory turnover | ||||||||||
long term debt to capitalization | 0.02 - | 0.03 20.93% | 0.07 148.85% | 0.18 143.01% | 0.10 42.25% | |||||
net income per ebt | 1 - | 1 0% | 1 0% | 1.02 2.16% | 1.01 1.01% | 1.00 0.67% | 1.01 0.67% | 1.00 1.52% | 1 0.41% | |
net profit margin | -34.12 - | -10.61 68.89% | -14.20 33.79% | -2.96 79.18% | -42.40 1,334.50% | -9.24 78.20% | ||||
operating cash flow per share | -0.08 - | -0.29 260.07% | -0.59 104.27% | -1.31 122.08% | -1.40 6.51% | -1.13 18.93% | -1.24 9.60% | -1.17 5.53% | -0.87 25.52% | |
operating cycle | 112.89 - | |||||||||
operating profit margin | -33.87 - | -10.63 68.60% | -14.28 34.30% | -2.93 79.51% | -42.74 1,361.01% | -9.47 77.84% | ||||
payables turnover | 0.98 - | |||||||||
pretax profit margin | -33.39 - | -10.49 68.58% | -14.13 34.68% | -2.92 79.32% | -42.57 1,356.66% | -9.24 78.29% | ||||
price fair value | 34.60 - | 15.82 54.28% | 3.90 75.37% | 2.79 28.51% | 6.41 130.14% | 4.55 29.05% | 5.40 18.79% | 1.55 71.37% | 3.26 110.57% | |
receivables turnover | 4.58 - | 2.23 51.42% | 4.75 113.66% | 21.75 357.45% | 3.23 85.13% | |||||
return on assets | -0.26 - | -0.47 78.42% | -0.35 26.24% | -0.86 147.63% | -0.51 40.36% | -0.45 12.21% | -0.53 17.68% | -0.58 9.23% | -0.82 42.56% | |
return on capital employed | -0.28 - | -0.50 82.01% | -0.38 25.09% | -0.99 162.12% | -0.61 37.95% | -0.54 11.75% | -0.62 14.37% | -0.67 7.83% | -1.17 75.23% | |
return on equity | -0.28 - | -0.50 81.55% | -0.38 25.27% | -1.15 204.26% | -0.67 41.41% | -0.57 15.59% | -0.67 18.81% | -0.80 19.21% | -1.37 70.19% | |
total debt to capitalization | 0.04 - | 0.10 - | 0.08 13.49% | 0.13 60.25% | 0.23 70.77% | 0.24 4.39% |
All numbers in USD (except ratios and percentages)